Hindustan Bio Sciences Ltd
NSE: BSE: 532041
₹7.80
(-2.50%)
Thu, 26 Mar 2026, 06:28 pm
Market Cap79.96M
PE Ratio55.01
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KHindustan Bio Sciences Financials
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.29M | 37.42M | 39.00M | 37.35M | 27.06M | 38.90M | 22.54M | 7.50M | 12.60M | 10.12M | 10.31M | 35.63M | 19.42M | 10.22M | 4.31M | 9.02M | 10.49M | 8.13M |
| Gross profit | 1.39M | 9.12M | 10.63M | 7.80M | 7.01M | 3.55M | -1.25M | -9.94M | 1.13M | 68.24K | 2.34M | 5.01M | 4.33M | 1.47M | 97.80K | 1.47M | 3.14M | 2.53M |
| Operating expenses (excl. COGS) | -2.33M | -7.92M | -7.28M | -4.41M | -7.63M | -10.47M | -7.72M | -4.09M | -2.47M | -4.83M | -25.93M | -3.78M | -3.09M | -2.95M | -4.62M | -2.01M | -2.61M | -1.51M |
| Selling/general/admin expenses, total | -2.13M | -7.71M | -7.28M | -4.41M | -7.63M | -10.47M | -7.72M | -3.97M | -2.47M | -4.83M | -25.93M | -3.78M | -3.09M | -2.95M | -4.62M | -2.01M | -2.61M | -1.51M |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | 0 | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -2.13M | -7.71M | -7.28M | -4.41M | -7.63M | -10.47M | -7.72M | -3.97M | -2.47M | -4.83M | -25.93M | -3.78M | -3.09M | -2.95M | -4.62M | -2.01M | -2.61M | -1.51M |
| Other operating expenses, total | -209.76K | -210.91K | 0 | 0 | 0 | 0 | 0 | -115.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -520 | 0 |
| Operating income | -945.65K | 1.20M | 3.35M | 3.39M | -621.82K | -6.92M | -8.97M | -14.03M | -1.34M | -4.76M | -23.60M | 1.23M | 1.24M | -1.48M | -4.53M | -538.91K | 531.80K | 1.02M |
| Non-operating income, total | 798.68K | -56.77K | -5.48M | -3.07M | -244.80K | -246.50K | -952.34K | -449.13K | -19.49M | -110.44K | 883.88K | -106.97K | -73.27K | -8.07M | -619.15K | 159.42K | 1.60K | -37.00K |
| Interest expense, net of interest capitalized | -1.05K | -4.35K | -190.92K | -191.56K | -205.71K | -214.99K | -277.48K | -312.85K | -259.95K | -110.44K | -37.73K | -103.43K | -81.84K | -68.71K | -49.79K | -40.97K | -36.86K | -14.00K |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 799.73K | -52.42K | 360.04K | -2.88M | -39.09K | -31.51K | -674.86K | -136.28K | 0 | 0 | 921.61K | -3.54K | 8.57K | 17.60K | -569.36K | 200.39K | 38.46K | -23.00K |
| Non-operating interest income | 2.63K | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Miscellaneous non-operating expense | 797.10K | -52.42K | 360.04K | -2.88M | -39.09K | -31.51K | -674.86K | -136.28K | 0 | 0 | 921.61K | -3.54K | 8.57K | 17.60K | -569.36K | 200.39K | 38.46K | -23.00K |
| Unusual income/expense | — | — | -5.65M | — | — | — | — | — | -19.23M | — | — | — | 0 | -8.02M | 0 | 0 | 0 | 0 |
| Pretax income | -146.97K | 1.14M | -2.14M | 318.81K | -866.62K | -7.17M | -9.92M | -14.48M | -20.83M | -4.87M | -22.71M | 1.12M | 1.16M | -9.55M | -5.14M | -379.49K | 533.40K | 982.00K |
| Taxes | 29.44K | -146.98K | 95.15K | -235.54K | 1.08K | -2.56K | 1.77K | -71.75K | -48.71K | -41.77K | -40.47K | -23.52K | -355.93K | 154.88K | -30.50K | -25.04K | 42.54K | 25.00K |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -117.53K | 994.55K | -2.04M | 83.28K | -865.54K | -7.17M | -9.92M | -14.55M | -20.88M | -4.92M | -22.75M | 1.10M | 808.73K | -9.40M | -5.18M | -404.53K | 575.94K | 1.01M |
| Net income | -117.53K | 994.55K | -2.04M | 83.28K | -865.54K | -7.17M | -9.92M | -14.55M | -20.88M | -4.92M | -22.75M | 1.10M | 808.73K | -9.40M | -5.18M | -404.53K | 575.94K | 1.01M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -117.53K | 994.55K | -2.04M | 83.28K | -865.54K | -7.17M | -9.92M | -14.55M | -20.88M | -4.92M | -22.75M | 1.10M | 808.73K | -9.40M | -5.18M | -404.53K | 575.94K | 1.01M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 1.36M | 3.40M | 4.72M | 6.04M | 2.02M | -4.21M | -6.80M | -12.19M | -1.23M | -4.66M | -23.50M | 1.34M | 1.35M | -1.40M | -4.49M | -482.35K | 600.29K | 1.02M |
| EBIT | -945.65K | 1.20M | 3.35M | 3.39M | -621.82K | -6.92M | -8.97M | -14.03M | -1.34M | -4.76M | -23.60M | 1.23M | 1.24M | -1.48M | -4.53M | -538.91K | 531.80K | 1.02M |
| Total operating expenses | -16.24M | -36.22M | -35.66M | -33.96M | -27.68M | -45.83M | -31.51M | -21.53M | -13.94M | -14.89M | -33.91M | -34.40M | -18.19M | -11.69M | -8.83M | -9.56M | -9.96M | -7.11M |
| Prepaid expenses | 122.05K | 100.31K | 36.12K | 12.98K | 11.27K | 40.27K | — | — | 11.67K | — | — | — | — | 3.46M | 2.80M | 1.94M | 1.79M | 1.79M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred income, non-current | — | — | — | — | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800